Diclofenac has same CV risks as withdrawn COX-2 blocker
Links shared publicly online about this topic.
- 1,108total visits
Diclofenac has same CV risks as withdrawn COX-2 blocker
A new observational study looking at the entire Danish population has found that the commonly used NSAID diclofenac has similar cardiovascular risks to the withdrawn COX-2 inhibitor rofecoxib, in healthy people. Given that diclofenac is widely used and available over the counter in many countries, these findings are worrying, say the researchers.
View full resource at theheart.org
Tags: Osteoarthritis Medication, Rheumatoid Arthritis Medication, NSAIDs, COX-2 Inhibitor, Voltaren, Cataflam, Vioxx
Most Recently Shared on June 8, 2010 at 8:27 pm By:
Diclofenac: Similar CV risk to rofecoxib in healthy people: A new observational study looking at the entire Danish... http://bit.ly/avXmC4
Advertisement
